tyrphostin ag 1024 has been researched along with Experimental Neoplasms in 1 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia-Echeverria, C | 1 |
1 other study available for tyrphostin ag 1024 and Experimental Neoplasms
| Article | Year |
|---|---|
Medicinal chemistry approaches to target the kinase activity of IGF-1R.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Benzimidazoles; Drug Evaluation, Preclinical | 2006 |